First Detection of DS-1-like G1P[8] Double-gene Reassortant Rotavirus Strains on The American Continent, Brazil, 2013

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP LUCHS, Adriana
COSTA, Antonio Charlys da FMUSP-HC
CILLI, Audrey
KOMNINAKIS, Shirley Cavalcante Vasconcelos
CARMONA, Rita de Cassia Compagnoli
MORILLO, Simone Guadagnucci
SABINO, Ester Cerdeira FMUSP-HC
TIMENETSKY, Maria do Carmo Sampaio Tavares 2019
dc.identifier.citation SCIENTIFIC REPORTS, v.9, article ID 2210, 7p, 2019
dc.identifier.issn 2045-2322
dc.description.abstract Emergence of DS-1-like-G1P[8] rotavirus in Asia have been recently reported. We report for the first time the detection and the whole genome phylogenetic analysis of DS-1-like-G1P[8] strains in America. From 2013 to 2017, a total of 4226 fecal samples were screened for rotavirus by ELISA, PAGE, RT-PCR and sequencing. G1P[8] represented 3.7% (30/800) of all rotavirus-positive samples. DS-1-like-G1P[8] comprised 1.6% (13/800) detected exclusively in 2013, and Wa-like-G1P[8] comprised 2.1% (17/800) detected from 2013 to 2015. Whole genome sequencing confirmed the DS-1-like backbone I2-R2-C2-M2-A2-N2-T2-E2-H2. All genome segments of the Brazilian DS-1-like-G1P[8] strains clustered with those of Asian strains, and apart from African DS-1-like-G1P[8] strains. In addition, Brazilian DS-1-likeG1P[8] reassortants distantly clustered with DS-1-like backbone strains simultaneously circulating in the country, suggesting that the Brazilian DS-1-like-G1P[8] strains are likely imported from Asia. Two distinct NSP4 E2 genotype lineages were also identified, indicating the existence of a co-circulating pool of different DS-1-like G1P[8] strains. Surveillance systems must be developed to examine if RVA vaccines are still effective for the prevention against unusual DS-1-like-G1P[8] strains.
dc.description.sponsorship · Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technological Development) [400354/2016-0]
dc.language.iso eng
dc.relation.ispartof Scientific Reports
dc.rights openAccess
dc.subject.other equine-like; vaccine introduction; nucleic-acid; g3 rotavirus; gastroenteritis; children; japan; prevalence; emergence; mortality
dc.title First Detection of DS-1-like G1P[8] Double-gene Reassortant Rotavirus Strains on The American Continent, Brazil, 2013
dc.type article
dc.rights.holder Copyright NATURE PUBLISHING GROUP LIM/46
dc.identifier.doi 10.1038/s41598-019-38703-7
dc.identifier.pmid 30778110
dc.type.category original article
dc.type.version publishedVersion COSTA, Antonio Charlys da:IMT: SABINO, Ester Cerdeira:FM:MIP · LUCHS, Adriana:Adolfo Lutz Inst, Virol Ctr, Enter Dis Lab, Sao Paulo, Brazil
· CILLI, Audrey:Adolfo Lutz Inst, Virol Ctr, Enter Dis Lab, Sao Paulo, Brazil
· KOMNINAKIS, Shirley Cavalcante Vasconcelos:Fac Med ABC, Postgrad Program Hlth Sci, Santo Andre, Brazil; Univ Fed Sao Paulo, Retrovirol Lab, Sao Paulo, SP, Brazil
· CARMONA, Rita de Cassia Compagnoli:Adolfo Lutz Inst, Virol Ctr, Enter Dis Lab, Sao Paulo, Brazil
· MORILLO, Simone Guadagnucci:Adolfo Lutz Inst, Virol Ctr, Enter Dis Lab, Sao Paulo, Brazil
· TIMENETSKY, Maria do Carmo Sampaio Tavares:Adolfo Lutz Inst, Virol Ctr, Enter Dis Lab, Sao Paulo, Brazil WOS:000458862200013 2-s2.0-85061714233 LONDON ENGLAND
hcfmusp.relation.reference · Aida S, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00168
· Arana A, 2016, INFECT GENET EVOL, V44, P137, DOI 10.1016/j.meegid.2016.06.048
· Arista S, 2006, J VIROL, V80, P10724, DOI 10.1128/JVI.00340-06
· Beltrao K. I., 2016, REV BRAS ESTUD POPUL, V23, P61
· Cowley D, 2016, J GEN VIROL, V97, P403, DOI 10.1099/jgv.0.000352
· da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
· Deng XT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv002
· Desai R, 2012, CLIN INFECT DIS, V55, pE28, DOI 10.1093/cid/cis443
· Desai R, 2011, MEM I OSWALDO CRUZ, V106, P907, DOI 10.1590/S0074-02762011000800002
· Doan YH, 2015, INFECT GENET EVOL, V34, P423, DOI 10.1016/j.meegid.2015.05.026
· Doro R, 2016, ACTA MICROBIOL IMM H, V63, P243, DOI 10.1556/030.63.2016.2.8
· Flannery B, 2013, VACCINE, V31, P1523, DOI 10.1016/j.vaccine.2013.01.004
· Fujii Y, 2014, INFECT GENET EVOL, V28, P426, DOI 10.1016/j.meegid.2014.08.001
· Gomez MM, 2014, INFECT GENET EVOL, V28, P486, DOI 10.1016/j.meegid.2014.09.012
· GOUVEA V, 1994, J CLIN MICROBIOL, V32, P1333
· Guntapong R, 2017, J MED VIROL, V89, P615, DOI 10.1002/jmv.24669
· Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI 10.1021/BK-1999-0734.CH008
· Jere KC, 2018, J VIROL, V92, DOI 10.1128/JVI.01246-17
· Kapikian A. Z, 1996, FIELDS VIROLOGY, P1625
· Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
· Komoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148416
· Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054
· LI BG, 1993, VIROLOGY, V196, P825, DOI 10.1006/viro.1993.1540
· Luchs A, 2016, ACTA TROP, V156, P87, DOI 10.1016/j.actatropica.2015.12.008
· Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238
· da Silva MFM, 2015, INFECT GENET EVOL, V30, P206, DOI 10.1016/j.meegid.2014.12.030
· McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634
· Nakagomi T, 2017, ARCH VIROL, V162, P739, DOI 10.1007/s00705-016-3155-6
· Paternina-Caicedo A, 2015, VACCINE, V33, P3923, DOI 10.1016/j.vaccine.2015.06.058
· Perkins C, 2017, MICROBIOL RESOUR ANN, V5, DOI 10.1128/genomeA.01341-17
· Phan TG, 2007, J VIROL, V81, P10188, DOI 10.1128/JVI.00337-07
· Guerra SFS, 2016, J GEN VIROL, V97, P3131, DOI 10.1099/jgv.0.000626
· Yamamoto D, 2017, New Microbes New Infect, V18, P54, DOI 10.1016/j.nmni.2017.04.001
· Yamamoto SP, 2014, EMERG INFECT DIS, V20, P1030, DOI 10.3201/eid2006.131326
dc.description.index MEDLINE
hcfmusp.citation.scopus 0
hcfmusp.citation.wos 0 Brasil

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


My Account